Ultramicrosize Griseofulvin Tablet, Coated
Product Images NDC 0115-1724

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ultramicrosize Griseofulvin (NDC 0115-1724). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ultramicrosize Griseofulvin Tablets 1)

Chemical structure of Ultramicrosize Griseofulvin, showing its molecular formula C17H17ClO6 and molecular weight 352.77.*

FDA Label Image

125 mg, 100 Tablets (NDC 0115-1724-01)

Label for Ultramicrosize Griseofulvin Tablets, USP 125 mg, coated oral tablets. The label shows the product name, strength of 125 mg per tablet, and quantity of 100 tablets. Manufactured by ANI Pharmaceuticals, Inc. and for Amneal Pharmaceuticals LLC. It includes storage instructions, dosage directions reference, barcode, and the NDC number 0115-1724-01.*

FDA Label Image

250 mg, 100 Tablets (NDC 0115-1725-01)

Label for Ultramicrosize Griseofulvin Tablets USP, 250 mg oral coated tablets, in a package containing 100 tablets. The label includes dosage information, storage instructions to keep at 20° to 25°C, and notes it is Rx only. The product is manufactured by ANI Pharmaceuticals, Inc. and for Amneal Pharmaceuticals LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.